Related Experiment Video
Updated: Aug 9, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
Outcomes in African Americans and Hispanics with lupus nephritis
1Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Florida 33136, USA. gcontrer@med.miami.edu
Insights
African Americans and Hispanics with lupus nephritis face worse outcomes due to aggressive disease factors and lower income. This study identified predictors of these poorer lupus nephritis outcomes in minority groups.
Area of Science:
- Nephrology
- Immunology
- Public Health
Background:
- Lupus nephritis disproportionately affects African Americans and Hispanics, leading to poorer health outcomes compared to Caucasians.
- Understanding the specific predictors of outcomes in these populations is crucial for targeted interventions.
Purpose of the Study:
- To identify independent predictors of outcomes in African Americans and Hispanics diagnosed with lupus nephritis.
- To compare baseline characteristics and outcomes across different racial and ethnic groups.
Main Methods:
- Retrospective analysis of 93 African Americans, 100 Hispanics, and 20 Caucasians with lupus nephritis.
- Data collected included demographics, World Health Organization (WHO) lupus nephritis class, mean arterial pressure (MAP), serum creatinine, hematocrit, and household income.
Main Results:
- African Americans exhibited higher MAP and serum creatinine, and lower hematocrit and income compared to Hispanics and Caucasians.
- Hispanics and African Americans showed a higher prevalence of WHO class IV lupus nephritis and a greater incidence of doubling creatinine, end-stage renal disease, or renal events/death.
- Lower household income was identified as a common factor in African Americans and Hispanics.
Conclusions:
- Both aggressive disease characteristics and socioeconomic factors like low household income contribute to the poorer outcomes observed in African Americans and Hispanics with lupus nephritis.
- These findings underscore the need for interventions addressing both biological and social determinants of health in lupus nephritis management for minority populations.
Abstract:
Poor outcomes have been reported in African Americans and Hispanics compared to Caucasians with lupus nephritis. The purpose of this retrospective analysis was to identify independent predictors of outcomes in African Americans and Hispanics with lupus nephritis. In total, 93 African Americans, 100 Hispanics, and 20 Caucasians with a mean age of 28 +/- 13 years and an annual household income of 32.9 +/- 17.3 (in 1000 US dollars) were studied. World Health Organization (WHO) lupus nephritis classes II, III, IV, and V were seen in 9, 13, 52, and 26%, respectively. Important baseline differences were higher mean arterial pressure (MAP) in African Americans compared to Hispanics and Caucasians (107 +/- 19, 102 +/- 15, and 99 +/- 13 mmHg, P < 0.05), and higher serum creatinine (1.66 +/- 1.3, 1.25 +/- 1.0, and 1.31 +/- 1.0 mg/dl, P < 0.025). African Americans had lower hematocrit compared to Hispanics and Caucasians (29 +/- 5, and 31 +/- 6, and 32 +/- 7%, P < 0.05), and lower annual household income (30.8 +/- 14.9, 33.1 +/- 15.9, and 42.2 +/- 29.3 in 1000 US dollars; P < 0.05). Lower prevalence of WHO class IV was seen in Caucasians (30%) compared to Hispanics (57%, P = 0.03) and African Americans (51%, P = 0.09). Development of doubling creatinine or end-stage renal disease was higher in African Americans and Hispanics than in Caucasians (31, 18, and 10%; P < 0.05), as was the development of renal events or death (34, 20, and 10%; P < 0.025). Our results suggest that both biological factors indicating an aggressive disease and low household income are common in African Americans and Hispanics with lupus nephritis, and outcomes in these groups are worse than in Caucasians.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

